人类乳腺癌驱动因素,脆弱性和耐药性的功能性基因组景观
Richard Marcotte1, Azin Sayad1, Kevin R Brown2
1Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
研究人员使用全基因组查发现了新的乳腺癌脆弱性. 这项研究揭示了潜在的药物标和抗药机制,为癌症功能基因组学提供了洞察力.
科学领域:
- 基因组学
- 癌症生物学
- 药物发现
背景情况:
- 大规模的基因组研究揭示了乳腺癌的许多体质异常,例如拷贝数变化和点突变.
- 在乳腺癌研究中,鉴定遗传变异导致的因果变异和新出现的脆弱性是一个重大挑战.
研究的目的:
- 通过全基因组shRNA脱落查,识别乳腺癌的新脆弱性和功能性基因组特性.
- 将查数据与遗传和蛋白质组信息相结合,以发现候选驱动基因.
- 探索潜在的治疗策略,包括药物耐药性机制和组合疗法.
主要方法:
- 在77个乳腺癌细胞系中进行全基因小毛RNA (shRNA) 脱落查.
- 使用等级线性回归算法来得分.
- 综合查数据与全面的遗传和蛋白质组信息.
主要成果:
- 确定了乳腺癌的关键漏洞和候选驱动基因.
- 揭示了癌细胞的一般功能基因组特性.
- 将基因关键性数据与药物敏感性联系起来,表明耐药性机制和组合治疗机会.
- 确定BRD4作为潜在的治疗点在乳腺癌.
- 发现PIK3CA突变是BET抑制剂耐药性的决定因素.
结论:
- 这项研究为了解乳腺癌功能基因组学和确定治疗点提供了有价值的数据集.
- BRD4成为潜在的乳腺癌治疗点.
- PIK3CA突变赋予了对BET抑制剂的耐药性,为未来的治疗策略提供了信息.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Treatment Resistant Cancers
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
Adaptive Mechanisms in Cancer Cells
